Raveena Shree R
Research Subjects
Research Interests
Raveena Shree R has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Amani Abdalbagi Eshag Hassan
Department of Pharmacology, Karnataka College of Pharmacy, Bangalore, India
1 shared publication - Deepak Kumar Jha
Department of Pharmacology, Karnataka College of Pharmacy, Bangalore, Karnataka, India
1 shared publication
Latest Publications
- Open Access
- 1 July 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21 (2) , 425-435
A Review on Skin Cancer and New Treatment Approach
Skin cancer is a most common disease classified into "melanomas,” which predominantly generates from melanocytes (the cells responsible for producing melanin), and "non-melanomas,” which is comprised of “basal cell carcinoma," which arises from the basal cell located in the deepest layer of the epidermis, and “squamous cell carcinoma,” which originates from the squamous cell found within the epidermal layer. It is influenced by both non-biological (UV rays and environmental exposure) and biological factors, such as genetics and types of skin. For better treatment, initial detection of cancer plays a vital role. Prevention and management of skin cancer requires changes in lifestyle, routine screenings, and modern medical treatments. Some of which are our hope include advancements in imaging techniques, immunotherapy, genetic markers, and plant-based management. As skin cancer cases are increasing worldwide, it is essential to explore various treatment and prevention strategies. Prevention and treatment of skin cancer and patient outcomes could improve by developing medical devices and novel therapeutic approaches. Initial detection, routine screening, and a blend of conventional and innovative treatments are crucial for fighting this widespread disease.
- 1 July 2024
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 21 (2) , 425-435
Open AccessA Review on Skin Cancer and New Treatment Approach
Skin cancer is a most common disease classified into "melanomas,” which predominantly generates from melanocytes (the cells responsible for producing melanin), and "non-melanomas,” which is comprised of “basal cell carcinoma," which arises from the basal cell located in the deepest layer of the epidermis, and “squamous cell carcinoma,” which originates from the squamous cell found within the epidermal layer. It is influenced by both non-biological (UV rays and environmental exposure) and biological factors, such as genetics and types of skin. For better treatment, initial detection of cancer plays a vital role. Prevention and management of skin cancer requires changes in lifestyle, routine screenings, and modern medical treatments. Some of which are our hope include advancements in imaging techniques, immunotherapy, genetic markers, and plant-based management. As skin cancer cases are increasing worldwide, it is essential to explore various treatment and prevention strategies. Prevention and treatment of skin cancer and patient outcomes could improve by developing medical devices and novel therapeutic approaches. Initial detection, routine screening, and a blend of conventional and innovative treatments are crucial for fighting this widespread disease.